Adrhyan Araújo
Research Subjects
Adrhyan Araújo has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ana Maísa Passos-Silva
Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia—FIOCRUZ/RO, Porto Velho 76812-245, Brazil
3 shared publications - Deusilene Vieira
Laboratório de Virologia Molecular, Fundação Oswaldo Cruz Rondônia - FIOCRUZ/RO, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, Universidade Federal de Rondônia - UNIR, Porto Velho, RO, Brazil; Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, RO, Brazil; Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental - INCT-EpiAmO, Porto Velho, RO, Brazil
3 shared publications - Eugênia de Castro e Silva
Centro de Pesquisa em Medicina Tropical – CEPEM, Porto Velho, Brazil
2 shared publications - Juan Miguel Villalobos Salcedo
Universidade Federal de Rondônia, Brazil
2 shared publications - Lourdes Maria Pinheiro Borzacov
Centro de Pesquisa em Medicina Tropical – CEPEM, Porto Velho, Brazil
2 shared publications - Alexandre Rodrigues Calazans
Instituto de Tecnologia em Imunobiologia Bio-Manguinhos, Rio de Janeiro, Brazil
1 shared publication
Latest Publications
- Open Access
- 12 February 2026
- Published by Universidade Federal de Sao Paulo in Revista Neurociências
- Vol. 34, 1-17
Aspectos epidemiológicos da esquizofrenia em um CAPS de Rondônia, Brasil
ResumenIntroducción. La esquizofrenia es un trastorno neuropsiquiátrico que altera la percepción, el pensamiento, las emociones y la conciencia. Es la forma más común de psicosis, afectando a aproximadamente 20 millones de personas en todo el mundo. Objetivo. Identificar el perfil epidemiológico de los pacientes diagnosticados con esquizofrenia en Porto Velho, Rondônia. Método. Se trata de un estudio descriptivo, transversal, con un enfoque cualitativo-cuantitativo, realizado en un Centro de Atención Psicosocial (CAPS). Resultados. Se recopilaron datos de 200 historias clínicas de pacientes activos, enfocándose en variables como sexo, edad, estado civil, nivel educativo, religión, diagnóstico CIE-10, tratamiento farmacológico y antecedentes familiares. De estos, 47 registros (23,5%) correspondían a trastornos del espectro de la esquizofrenia (CIE-10: F20–F29), con un 53,2% de hombres y un 46,8% de mujeres, y una edad media de 45±3 años. La mayoría de los pacientes eran solteros (57,4%), no habían completado la educación primaria (38,3%) y se identificaban como católicos o evangélicos (27,7% cada uno). La esquizofrenia no especificada (F20) (40,43%) y la esquizofrenia paranoide (F20.0) (17,02%) fueron los diagnósticos más frecuentes. El tratamiento farmacológico se registró en el 97,9% de los casos, y el 9% tenía antecedentes familiares de enfermedad mental. Conclusión. Comprender este perfil contribuye a una mejor planificación de estrategias de salud pública y al fortalecimiento de los servicios de salud mental.
- 12 February 2026
- Published by Universidade Federal de Sao Paulo in Revista Neurociências
- Vol. 34, 1-17
Open AccessAspectos epidemiológicos da esquizofrenia em um CAPS de Rondônia, Brasil
ResumenIntroducción. La esquizofrenia es un trastorno neuropsiquiátrico que altera la percepción, el pensamiento, las emociones y la conciencia. Es la forma más común de psicosis, afectando a aproximadamente 20 millones de personas en todo el mundo. Objetivo. Identificar el perfil epidemiológico de los pacientes diagnosticados con esquizofrenia en Porto Velho, Rondônia. Método. Se trata de un estudio descriptivo, transversal, con un enfoque cualitativo-cuantitativo, realizado en un Centro de Atención Psicosocial (CAPS). Resultados. Se recopilaron datos de 200 historias clínicas de pacientes activos, enfocándose en variables como sexo, edad, estado civil, nivel educativo, religión, diagnóstico CIE-10, tratamiento farmacológico y antecedentes familiares. De estos, 47 registros (23,5%) correspondían a trastornos del espectro de la esquizofrenia (CIE-10: F20–F29), con un 53,2% de hombres y un 46,8% de mujeres, y una edad media de 45±3 años. La mayoría de los pacientes eran solteros (57,4%), no habían completado la educación primaria (38,3%) y se identificaban como católicos o evangélicos (27,7% cada uno). La esquizofrenia no especificada (F20) (40,43%) y la esquizofrenia paranoide (F20.0) (17,02%) fueron los diagnósticos más frecuentes. El tratamiento farmacológico se registró en el 97,9% de los casos, y el 9% tenía antecedentes familiares de enfermedad mental. Conclusión. Comprender este perfil contribuye a una mejor planificación de estrategias de salud pública y al fortalecimiento de los servicios de salud mental.
- Open Access
- 21 November 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 383
Evaluation of HDV stability under different biological sample collection and storage conditions: implications for molecular diagnosis
In Brazil, the Amazon region has the highest rate of infection by the hepatitis Delta virus, and owing to regional difficulties in transporting and storing samples, especially in remote regions and isolated populations, the expansion of molecular diagnosis has become a significant public health problem. This study aims to analyze the stability of HDV under different temperature and storage conditions, providing essential information for the expansion of the molecular diagnosis of Hepatitis Delta. Whole blood, serum, and plasma samples were collected from chronic HDV patients. The samples were subjected to different temperatures and storage conditions, and HDV-RNA detection was performed via RT-qPCR. HDV was stable under various temperature conditions, including high temperatures, with minimal variations in Ct values. Compared with cryopreserved samples, DBS samples presented greater variation. The results suggest that HDV can remain detectable for up to 96 h when stored at room temperature, 4 °C, -30 °C, and − 80 °C and for up to 72 h at temperatures ranging from 4 °C to 42 °C, in addition to the possibility of detection via filter paper, although with reduced sensitivity. HDV is stable under different conditions, which is crucial for molecular diagnostics in regions with adverse storage conditions.
- 21 November 2025
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 383
Open AccessEvaluation of HDV stability under different biological sample collection and storage conditions: implications for molecular diagnosis
In Brazil, the Amazon region has the highest rate of infection by the hepatitis Delta virus, and owing to regional difficulties in transporting and storing samples, especially in remote regions and isolated populations, the expansion of molecular diagnosis has become a significant public health problem. This study aims to analyze the stability of HDV under different temperature and storage conditions, providing essential information for the expansion of the molecular diagnosis of Hepatitis Delta. Whole blood, serum, and plasma samples were collected from chronic HDV patients. The samples were subjected to different temperatures and storage conditions, and HDV-RNA detection was performed via RT-qPCR. HDV was stable under various temperature conditions, including high temperatures, with minimal variations in Ct values. Compared with cryopreserved samples, DBS samples presented greater variation. The results suggest that HDV can remain detectable for up to 96 h when stored at room temperature, 4 °C, -30 °C, and − 80 °C and for up to 72 h at temperatures ranging from 4 °C to 42 °C, in addition to the possibility of detection via filter paper, although with reduced sensitivity. HDV is stable under different conditions, which is crucial for molecular diagnostics in regions with adverse storage conditions.
- Open Access
- 30 April 2025
- Published by SAGE Publications in Biomedical Engineering and Computational Biology
- Vol. 16
Screening Biomarkers and Risk Factors for COVID-19 Progression in a Border Population Between Brazil-Bolivia
Background: The performance and genetic role in host response delineate investigative points of polymorphisms as potential biomarkers in viral infections. Methods: Thus, this research aimed to map biomarkers and risk factors in the severity of COVID-19 in individuals in Western Amazon (n = 243). Results: Patients aged 40 to 59 years showed an association with clinical progression ( P = .003), also evidencing the relationship for individuals >60 years ( P < .001), besides the non-vaccination influenced the pathology ( P = .023). qPCR for human genotyping of the targets rs2070788, rs4702, rs76635825, rs540856718, rs35803318, rs12979860, and rs16899066, as well as for gene expression of ACE2, HLA-A, HLA-B, IFNL-3/2, IL-6, and TMPRSS2 was used. The rs12979860 (C > T) and rs2070788 (A > G) showed association among the analyzed groups ( P < .05) with the allelic and genotypic frequency of rs12979860 ( x 2 < 3.84) and evolutionary pointing of rs2070788G allele among infected people, including deaths. Conclusion: Gene expression showed high levels between the moderate and severe groups, with emphasis on TMPRSS2 and IL-6 genes that performed better. Thus, there is possibly an association regarding the role of the TMPRSS2 gene and rs2070788G, as well as age and IL-6 levels for COVID-19, pointing in parallel to the considerable influence of the vaccine on the SARS-CoV-2 pathway.
- 30 April 2025
- Published by SAGE Publications in Biomedical Engineering and Computational Biology
- Vol. 16
Open AccessScreening Biomarkers and Risk Factors for COVID-19 Progression in a Border Population Between Brazil-Bolivia
Background: The performance and genetic role in host response delineate investigative points of polymorphisms as potential biomarkers in viral infections. Methods: Thus, this research aimed to map biomarkers and risk factors in the severity of COVID-19 in individuals in Western Amazon (n = 243). Results: Patients aged 40 to 59 years showed an association with clinical progression ( P = .003), also evidencing the relationship for individuals >60 years ( P < .001), besides the non-vaccination influenced the pathology ( P = .023). qPCR for human genotyping of the targets rs2070788, rs4702, rs76635825, rs540856718, rs35803318, rs12979860, and rs16899066, as well as for gene expression of ACE2, HLA-A, HLA-B, IFNL-3/2, IL-6, and TMPRSS2 was used. The rs12979860 (C > T) and rs2070788 (A > G) showed association among the analyzed groups ( P < .05) with the allelic and genotypic frequency of rs12979860 ( x 2 < 3.84) and evolutionary pointing of rs2070788G allele among infected people, including deaths. Conclusion: Gene expression showed high levels between the moderate and severe groups, with emphasis on TMPRSS2 and IL-6 genes that performed better. Thus, there is possibly an association regarding the role of the TMPRSS2 gene and rs2070788G, as well as age and IL-6 levels for COVID-19, pointing in parallel to the considerable influence of the vaccine on the SARS-CoV-2 pathway.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 30, e20230025
Molecular genetic association of rs8099917 and rs1800795 polymorphisms in the progression of hepatitis Delta virus liver disease
The relationship between viral infections and host factors holds high hopes for identifying the role of Interferon Lambda 3 (IFNL3) and Interleukin 6 (IL-6) polymorphisms in the development of Chronic Liver Disease (CLD) in patients infected with hepatitis Delta virus (HDV) in the Western Brazilian Amazon.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 30, e20230025
Open AccessMolecular genetic association of rs8099917 and rs1800795 polymorphisms in the progression of hepatitis Delta virus liver disease
The relationship between viral infections and host factors holds high hopes for identifying the role of Interferon Lambda 3 (IFNL3) and Interleukin 6 (IL-6) polymorphisms in the development of Chronic Liver Disease (CLD) in patients infected with hepatitis Delta virus (HDV) in the Western Brazilian Amazon.